Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson Declares Cash Dividend for the Fourth Quarter of 2021, Payable on December 7, 2021

10/21/2021 | 02:38pm EST

Johnson & Johnson announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2021 of $1.06 per share on the company's common stock. The dividend is payable on December 7, 2021 to shareholders of record at the close of business on November 23, 2021. The ex-dividend date is November 22, 2021.


ę S&P Capital IQ 2021
All news about JOHNSON & JOHNSON
05:12pSCIENTISTS SCRAMBLE TO UNDERSTAND CO : What we know
AQ
03:41pJOHNSON & JOHNSON : How Johnson & Johnson is Using Technology To Revolutionize the Way We ..
PU
03:41pJOHNSON & JOHNSON : "I Want to Live a Life That's Not Defined By My Schizophrenia"
PU
12:51pBiden Says Administration Working With Vaccine Manufacturers on Contingency Plans to Co..
DJ
08:01aJOHNSON & JOHNSON : to Evaluate Its COVID-19 Vaccine Against New Omicron COVID-19 Variant
PU
04:45aCOVID-19 Vaccine Makers Working on Strategies Amid Omicron Variant
MT
03:06aEthiopia Launches a Covid-19 Vaccination Campaign Targeting the 12 Years and Above Popu..
AQ
11/26FDA Places Clinical Hold on Phase 3 Study for Ocugen COVID-19 Vaccine Covaxin
MT
11/25Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 ..
AQ
11/25CORONAVIRUS : Tanzania Broadens Choice for COVID - 19 Vaccines The government has so far a..
AQ
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 251 M - -
Net income 2021 22 542 M - -
Net Debt 2021 493 M - -
P/E ratio 2021 19,3x
Yield 2021 2,61%
Capitalization 421 B 421 B -
EV / Sales 2021 4,47x
EV / Sales 2022 4,16x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 159,75 $
Average target price 184,65 $
Spread / Average Target 15,6%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON1.16%419 109
ROCHE HOLDING AG16.05%336 162
PFIZER, INC.46.70%303 095
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049
ABBVIE INC.8.74%205 976